New DNA Repair Research May Influence Cancer Clinical Trials ‘For Years To Come’
September 16, 2024
On the road to future cancer treatments, Shan Yan. Ph.D., is blazing his own path.
That was evident recently when – as published in Nature Communications – Yan and his research team at UNC Charlotte broke new ground in the functional understanding of the protein APE1 that jumpstarts human DNA damage repair.
The findings could prove vital to future clinical trials, enabling scientists to possibly test whether therapeutic targeting of naturally occurring but overactive APE1 could improve cancer survival rates.
Read the full story on the Klein College of Science’s website.